Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Product
Deals
Articles
BioCentury
|
Feb 2, 2009
Strategy
Cardio build-up
...myocardial perfusion imaging Mkt Adenocard adenosine Adenosine A1 receptor agonist Atrial paroxysomal supraventricular tachycardia Mkt
BIBR277HCT
...
Read More
BioCentury
|
Feb 12, 2007
Clinical News
BIBR277HCT regulatory update
...Astellas filed an NDA in Japan for
BIBR277HCT
to treat hypertension. The product is a combination...
...U.K.) and Bayer AG (FSE:BAY; BAY, Leverkusen, Germany). Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Product:
BIBR277HCT
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page